Shares of Denmark’s Zealand Pharma popped nearly 23% in Friday morning deals, notching a record high after an early-stage study of its weight loss drug challenger produced positive results.
June 21, 2024 - 14:40
By Pharos Investment Advisors Comments are Off
Shares of Denmark’s Zealand Pharma popped nearly 23% in Friday morning deals, notching a record high after an early-stage study of its weight loss drug challenger produced positive results.
February 26, 2024 - 15:33
By Pharos Investment Advisors Comments are Off
Shares of Denmark’s Zealand Pharma shot 32% higher in morning trade, after results showed success in its liver disease treatment survodutide, which is also on trial as a drug to treat obesity.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014
Copyright 2023©. All Rights Reserved